Your browser doesn't support javascript.
loading
LncRNA NIPA1-SO confers atherosclerotic protection by suppressing the transmembrane protein NIPA1.
Jiang, Min; Song, Yu; Ren, Mei-Xia; He, Run-Chao; Dong, Xian-Hui; Li, Xue-Heng; Lu, Zhi-Feng; Li, Shu; Wu, Jia; Bei, Yan-Rou; Liu, Fei; Long, Yan; Wu, Shao-Guo; Liu, Xue-Hui; Wu, Li-Mei; Yang, Hong-Ling; McVey, David G; Dai, Xiao-Yan; Ye, Shu; Hu, Yan-Wei.
Afiliación
  • Jiang M; Department of Clinical Laboratory, Guangzhou Women & Children Medical Center, Guangzhou Medical University, Guangzhou 510620, China.
  • Song Y; Department of Clinical Laboratory, Guangzhou Women & Children Medical Center, Guangzhou Medical University, Guangzhou 510620, China.
  • Ren MX; Shengli Clinical Medical College of Fujian Medical University, Fujian Medical University, Fuzhou 350001, China; Department of Geriatric Medicine, Fujian Provincial Hospital, Fujian Key Laboratory of Geriatrics, Fujian Provincial Center for Geriatrics, Fuzhou 350013, China.
  • He RC; Department of Clinical Laboratory, Guangzhou Women & Children Medical Center, Guangzhou Medical University, Guangzhou 510620, China.
  • Dong XH; Department of Clinical Laboratory, Guangzhou Women & Children Medical Center, Guangzhou Medical University, Guangzhou 510620, China.
  • Li XH; Laboratory Medicine Center, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
  • Lu ZF; Laboratory Medicine Center, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
  • Li S; Department of Clinical Laboratory, Guangzhou Women & Children Medical Center, Guangzhou Medical University, Guangzhou 510620, China.
  • Wu J; Department of Clinical Laboratory, Guangzhou Women & Children Medical Center, Guangzhou Medical University, Guangzhou 510620, China.
  • Bei YR; Laboratory Medicine Center, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
  • Liu F; Department of Clinical Laboratory, Guangzhou Women & Children Medical Center, Guangzhou Medical University, Guangzhou 510620, China.
  • Long Y; Department of Clinical Laboratory, Guangzhou Women & Children Medical Center, Guangzhou Medical University, Guangzhou 510620, China.
  • Wu SG; Department of Clinical Laboratory, Guangzhou Twelfth People's Hospital, Guangzhou 510620, China.
  • Liu XH; Department of Clinical Laboratory, Guangzhou Twelfth People's Hospital, Guangzhou 510620, China.
  • Wu LM; Department of Clinical Laboratory, Guangzhou Twelfth People's Hospital, Guangzhou 510620, China.
  • Yang HL; Department of Clinical Laboratory, Guangzhou Women & Children Medical Center, Guangzhou Medical University, Guangzhou 510620, China.
  • McVey DG; Department of Cardiovascular Sciences & NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester LE3 9QP, UK.
  • Dai XY; Key Laboratory of Molecular Target & Clinical Pharmacology and the State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, Guangdong 511436, China. Electronic address: xdai@gzhmu.edu.cn.
  • Ye S; Cardiovascular Translational Research Programme, National University of Singapore, Singapore; Shantou University Medical College, Shantou, China. Electronic address: sy127@leicester.ac.uk.
  • Hu YW; Department of Clinical Laboratory, Guangzhou Women & Children Medical Center, Guangzhou Medical University, Guangzhou 510620, China; Laboratory Medicine Center, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. Electronic address: ywhu0618@163.com.
J Adv Res ; 54: 29-42, 2023 12.
Article en En | MEDLINE | ID: mdl-36736696

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Aterosclerosis / Placa Aterosclerótica / ARN Largo no Codificante Límite: Animals / Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Aterosclerosis / Placa Aterosclerótica / ARN Largo no Codificante Límite: Animals / Humans Idioma: En Año: 2023 Tipo del documento: Article